4//SEC Filing
McLaughlin Gerald W. 4
Accession 0001104659-20-029267
CIK 0001467652other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:22 PM ET
Size
7.0 KB
Accession
0001104659-20-029267
Insider Transaction Report
Form 4
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-02+395,000→ 395,000 totalExercise: $1.49Exp: 2030-03-02→ Common Stock (395,000 underlying) - Award
Common Stock
2020-03-02+290,000→ 314,500 total
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in two equal, annual installments beginning on March 2, 2021.
- [F2]This stock option will vest in four equal, annual installments beginning on March 2, 2021.
Documents
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Entity typeother
Related Parties
1- filerCIK 0001495412
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:22 PM ET
- Size
- 7.0 KB